Average Co-Inventor Count = 4.43
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (9 from 3,684 patents)
2. Incyte Corporation (4 from 666 patents)
3. Lexicon Pharmaceuticals, Inc. (3 from 86 patents)
16 patents:
1. 12415809 - Pyrrolotriazine compounds as tam inhibitors
2. 12187725 - Tricyclic urea compounds as JAK2 V617F inhibitors
3. 11780840 - Tricyclic urea compounds as JAK2 V617F inhibitors
4. 10723705 - Heterocyclic compounds and uses thereof
5. 9624238 - 4H-thieno[3,2-C]chromene-based inhibitors of Notum Pectinacetylesterase and methods of their use
6. 8772291 - Multicyclic compounds and methods of their use
7. 7981881 - Fused heterocyclic compounds and use thereof
8. 7601836 - Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
9. 7595317 - Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
10. 7384937 - Fused heterocyclic compounds and use thereof
11. 7300949 - Thiazolopyrazoles and methods of their use
12. 7294624 - Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
13. 7105667 - Fused heterocyclic compounds and use thereof
14. 7087614 - Pyrimidine inhibitors of phosphodiesterase (PDE) 7
15. 7022849 - Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7